Bidridistrogene Xeboparvovec
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Bidridistrogene Xeboparvovec, covering 2026-01-20 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4 [Phase 3]